Earnings ·
Kenvue reports Q3 diluted EPS of $0.22 as net sales rise 3.2% to $3.89 billion
KVUEKenvue Inc.
Kenvue Inc. reported fiscal third-quarter results ending September 27, 2026, with net sales increasing 3.2% year-over-year to $3.89 billion, driven by a 2.9% organic growth rate and a 0.3% foreign currency benefit. Diluted earnings per share rose 5% to $0.22, while adjusted diluted EPS increased 4% to $0.29. Operating income margin expanded to 18.2%, up from 16.7% in the prior year period. The company cited strong performance in its Self Care segment and margin expansion from productivity initiatives. Due to a pending transaction with Kimberly-Clark, Kenvue will not provide forward-looking guidance or host a quarterly conference call. Kenvue Inc. is the world’s largest pure-play consumer health company by revenue.